HSA-2023-0012-V312

Type IB variation for application HSA-2023-0012. Type IB variation: Labeling Change for Respiralimab — major revision

Variation Number
HSA-2023-0012-V312
Type
Type IB
Application
HSA-2023-0012
Change
CHG-2021-0012
Status
In Progress
Fee
€650
Submitted
2023-12-09
Approved
—
Description

Type IB variation: Labeling Change for Respiralimab — major revision